Julian Adams
2015
In 2015, Julian Adams earned a total compensation of $1.8M as President of R&D at Infinity Pharmaceuticals, a 54% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $87,150 |
---|---|
Option Awards | $1,233,275 |
Salary | $497,289 |
Other | $2,879 |
Total | $1,820,593 |
Adams received $1.2M in option awards, accounting for 68% of the total pay in 2015.
Adams also received $87.2K in non-equity incentive plan, $497.3K in salary and $2.9K in other compensation.
Rankings
In 2015, Julian Adams' compensation ranked 5,110th out of 13,638 executives tracked by ExecPay. In other words, Adams earned more than 62.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,110 out of 13,638 | 63rd |
Division Manufacturing | 1,887 out of 5,190 | 64th |
Major group Chemicals And Allied Products | 681 out of 1,854 | 63rd |
Industry group Drugs | 541 out of 1,528 | 65th |
Industry Pharmaceutical Preparations | 426 out of 1,182 | 64th |
Source: SEC filing on April 25, 2016.
Adams' colleagues
We found five more compensation records of executives who worked with Julian Adams at Infinity Pharmaceuticals in 2015.
2015
Adelene Perkins
Infinity Pharmaceuticals
Chief Executive Officer
2015
Sujay Kango
Infinity Pharmaceuticals
Chief Commercial Officer
2015
Lawrence Bloch
Infinity Pharmaceuticals
Chief Financial Officer
2015
David Roth
Infinity Pharmaceuticals
Chief Medical Officer
2015
Vito Palombella
Infinity Pharmaceuticals